Cabozantinib – BIOENGINEER.ORG https://bioengineer.org Bioengineering Wed, 26 Mar 2025 16:56:18 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png Cabozantinib – BIOENGINEER.ORG https://bioengineer.org 32 32 72741379 FDA Grants Approval for Innovative Dual-Action Therapy Targeting Previously Treated Advanced Neuroendocrine Tumors, Supported by Dana-Farber Research https://bioengineer.org/fda-grants-approval-for-innovative-dual-action-therapy-targeting-previously-treated-advanced-neuroendocrine-tumors-supported-by-dana-farber-research/ Wed, 26 Mar 2025 16:56:18 +0000 https://bioengineer.org/fda-grants-approval-for-innovative-dual-action-therapy-targeting-previously-treated-advanced-neuroendocrine-tumors-supported-by-dana-farber-research/ 239249